Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2000
09/26/2000US6124288 Phosphodiesterase iv inhibitors
09/26/2000US6124285 Indole-2,3-dione-3-oxime derivatives
09/26/2000US6124284 Bicyclic amide derivatives and their use as muscle relaxants
09/26/2000US6124283 Substituted 1,2,3,4-tetrahydronaphthalene derivatives
09/26/2000US6124282 Drug formulations
09/26/2000US6124281 Azolobenzazepine derivatives as neurologically active agents
09/26/2000US6124279 Neurokinin a antagonists, antiasthmatic agents
09/26/2000US6124278 Acylbenzoxazines for enhancing synaptic response
09/26/2000US6124276 Vitamin D derivative with substituent at the 2β-position
09/26/2000US6124274 Use of ascorbyl 2'-phosphates for stabilizing vitamin A and/or vitamin A derivatives in cosmetic and pharmaceutical preparations
09/26/2000US6124271 Method and conjugate for treating H. pylori infection
09/26/2000US6124270 Use of a cationic amphipathic compound as a transfection agent, vaccine additive or drug
09/26/2000US6124268 Natural antioxidant compositions, method for obtaining same and cosmetic, pharmaceutical and nutritional formulations thereof
09/26/2000US6124266 Sulphoquinovosyldiacylglycerol (sqdg) useful for prophylaxis or treatment of atopic dermatitis, urticaria and psoriasis, and as an antiproliferative agent
09/26/2000US6124264 Growth hormone secretagogue in a human or other animal to treat osteoporosis, congestive heart failure, aging, obesity; bone and wound healing agents
09/26/2000US6124119 Nucleotide sequences coding enzymatic polypeptide; for the treatment and prevention of bacterial infection; bactericides
09/26/2000US6124037 Surgical instrument with coating of polymerizable monomer such as (per)fluoroalkyl ether-substituted hydroxymethacrylic acid and its esters and amides, including ethoxylated, alkyl ammonium, and polyol substituents; coated ophthalmic device
09/26/2000US6123964 Wet granulation formulation of a growth hormone secretagogue
09/26/2000US6123962 Process for producing stabilized pharmaceutical composition
09/26/2000US6123953 Synergistic topical mixture of a 1,2-alkanediol of given formula and a clathrate glyceryl poly(meth)acrylate gel of given viscosity comprising 20-90% glycerin, 10-80% water and 0.1-5% weight of poly(meth)acrylate; preventing mastitis
09/26/2000US6123947 Herbal composition and treatment methods
09/26/2000US6123944 Immersing aerial parts of a plant of the genus epimedium in water, heating the water, removing debris, loading the aqueous incarrin containing solution on a column packed with a hydrophobic polymeric adsorber, washing, eluting, removing
09/26/2000US6123943 NF-KB activity inhibitor
09/26/2000US6123930 Consists of a combination of a compound selected from methionine, cysteine and s-carboxymethylcysteine and sodium tetraborate to treat the nails to increase the hardness and prevent their embrittlement
09/26/2000US6123928 Combining two ultraviolet a and b absorbing acrylic polymers comprising an unsubstitued acrylic acid or substituted acrylic acid with a side chain having oxygen or nitrogen atom covalently attached to polyacrylic acid with a carrier
09/26/2000CA2283470A1 Screening and therapy for lymphatic disorders involving the flt4 receptor tyrosine kinase (vegfr-3)
09/26/2000CA2270306C Pharmaceutical compositions comprising co-micronized fenofibrate
09/26/2000CA2253769C Pharmaceutical compositions comprising fenofibrate
09/26/2000CA2137832C Inhibitors of angiotensin i chymase(s) including human heart chymase
09/26/2000CA2126244C Suspension aerosol formulations
09/26/2000CA2064108C Thiazolidinone and oxazolidinone derivatives, their preparation and their use as vasodilators
09/26/2000CA2024572C N-substituted-4-pyrimidinamines and-pyrimidinediamines, a process for their preparation and their use as medicaments
09/26/2000CA1341102C Tetra-aza macrocycles and metal complexes thereof
09/21/2000WO2000055633A2 Methods of screening for colorectal cancer modulators
09/21/2000WO2000055377A1 SCREENING OF ANTIVIRAL COMPOUNDS TARGETED TO THE HIV-1 gp41 CORE STRUCTURE
09/21/2000WO2000055371A1 27 human secreted proteins
09/21/2000WO2000055352A2 50 human secreted proteins
09/21/2000WO2000055351A1 Human colon cancer associated gene sequences and polypeptides
09/21/2000WO2000055350A1 Human cancer associated gene sequences and polypeptides
09/21/2000WO2000055330A1 Polysaturated fatty acid (pufa) elongase from caenorhabditis elegans
09/21/2000WO2000055326A1 Chlamydia antigens and corresponding dna fragments and uses thereof
09/21/2000WO2000055323A1 Differential expression of organellar gene products
09/21/2000WO2000055320A1 Human pancreas and pancreatic cancer associated gene sequences and polypeptides
09/21/2000WO2000055201A1 49 human secreted proteins
09/21/2000WO2000055200A1 50 human secreted proteins
09/21/2000WO2000055194A2 Tuberculosis antigens and methods of use therefor
09/21/2000WO2000055180A2 Human lung cancer associated gene sequences and polypeptides
09/21/2000WO2000055174A1 Human prostate cancer associated gene sequences and polypeptides
09/21/2000WO2000055173A1 Human breast and ovarian cancer associated gene sequences and polypeptides
09/21/2000WO2000055171A1 50 human secreted proteins
09/21/2000WO2000055169A1 TCL-1b GENE AND PROTEIN AND RELATED METHODS AND COMPOSITIONS
09/21/2000WO2000055168A1 6-o-substituted macrolides having antibacterial activity
09/21/2000WO2000055162A2 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
09/21/2000WO2000055161A1 6-substituted biaryl purine derivatives as potent cyclin/cdk inhibitors and antiproliferative agents
09/21/2000WO2000055160A1 Pharmaceutical composition based on polyaromatic compounds
09/21/2000WO2000055159A2 Substituted aza-oxindole derivatives
09/21/2000WO2000055156A1 Substituted aromatic amidine derivative and medicinal composition comprising the same
09/21/2000WO2000055155A2 Heterocyclic compounds as adenosine deaminase inhibitors
09/21/2000WO2000055154A1 Modified amino-acid amides as cgrp antagonists
09/21/2000WO2000055153A1 Amide derivatives
09/21/2000WO2000055152A1 Aromatic heterocyclic compounds as anti-inflammatory agents
09/21/2000WO2000055150A1 Improved process for asymmetric hydrogenation
09/21/2000WO2000055149A1 Dimeric compounds and as inhibitors of neuraminidase
09/21/2000WO2000055147A1 Fused 1,4-thiazine-2-carbonitrile derivatives, their preparation and use
09/21/2000WO2000055144A1 Amine derivatives as protease inhibitors
09/21/2000WO2000055141A1 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, and processes for preparing them
09/21/2000WO2000055139A2 Heterocyclic urea and related compounds useful as anti-inflammatory agents
09/21/2000WO2000055137A1 Compounds and methods for modulation of estrogen receptors
09/21/2000WO2000055134A1 Substituted 1-oxo- and 1,3-dioxoisoindolines and their use in pharmaceutical compositions for reducing inflammatory cytokine levels
09/21/2000WO2000055133A1 1-acyl-7-nitroindoline derivatives, their preparation and their use as photocleavable precursors
09/21/2000WO2000055132A1 New salt of (2r,3r,4r)-3,4-dihydroxy-2-hydroxymethylpyrrolidine
09/21/2000WO2000055131A1 New salt of (2r,3r,4r)-3,4-dihydroxy-2-hydroxymethylpyrrolidine
09/21/2000WO2000055126A2 N-cyanomethylamides as protease inhibitors
09/21/2000WO2000055125A2 N-cyanomethyl amides as protease inhibitors
09/21/2000WO2000055120A1 Amide derivatives
09/21/2000WO2000055118A1 Nuclear receptor arylating compounds
09/21/2000WO2000055114A1 Substituted 2-aminobenzamide caspase inhibitors and the use thereof
09/21/2000WO2000055112A1 Anti-viral compounds
09/21/2000WO2000055109A1 Lipoxin compounds and their use
09/21/2000WO2000055072A2 Aerosol metering valve
09/21/2000WO2000054816A1 Method for the identification and removal of nits from hair
09/21/2000WO2000054811A1 Medicinal compositions
09/21/2000WO2000054810A1 Combination therapy for treating glaucoma
09/21/2000WO2000054809A1 Cervical ripening agent and cervical ripening method
09/21/2000WO2000054808A1 Prostaglandin ep4 receptor agonist and treatment method
09/21/2000WO2000054805A1 SURFACE LOCALIZED COLLIGIN/HsP47 IN CARCINOMA CELLS
09/21/2000WO2000054800A1 Preventives/remedies for digestive diseases
09/21/2000WO2000054796A1 Novel antiangiogenic peptides
09/21/2000WO2000054785A2 Stabilized bicyclo[3.3.1]nonenes and methods of use
09/21/2000WO2000054784A1 Complex comprising the coordination compound manganese, its medical effects and the mode of its production
09/21/2000WO2000054783A1 Treatment of asthma
09/21/2000WO2000054782A1 Treatment of accidental extravasation of anthracyclines
09/21/2000WO2000054781A1 Method for treatment of reactive arthritis or bursitis
09/21/2000WO2000054780A2 Corticosteroid formulation
09/21/2000WO2000054779A1 OCULAR THERAPY IN KERATOCONJUCTIVITIS SICCA USING TOPICALLY APPLIED ANDROGENS OR TGF-$g(b)
09/21/2000WO2000054778A1 Preventive or therapeutic agents for inflammatory dermatoses
09/21/2000WO2000054777A1 Controlled release of sildenafil delivered by sublingual or buccal administration
09/21/2000WO2000054776A1 Use of prolactin inhibitors for the treatment of fertility problems in animal species
09/21/2000WO2000054775A1 Stable pharmaceutical application form for paroxetin anhydrate
09/21/2000WO2000054774A1 Apomorphine and sildenafil composition
1 ... 6241 6242 6243 6244 6245 6246 6247 6248 6249 6250 6251 6252 6253 6254 6255 6256 6257 6258 6259 6260 6261 ... 7860